Healthcare Triangle Q2 FY26 gross profit more than doubled to $2.07 million; revenue more than doubled to $9.19 million
Reuters2026/08/13 12:15- Healthcare Triangle posted Q2 revenue of $9.19 million, more than doubled from a year earlier.
- Gross profit rose to $2.07 million; gross margin widened 8.7 percentage points to 22.5%.
- AI-powered customer engagement segment generated $6.31 million, about 69% of quarterly revenue.
- First-half revenue reached $19.05 million; gross profit climbed to $4.46 million.
- Stockholders’ equity increased to $49.1 million at June 30, from $9.9 million at Dec. 31.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Spot bitcoin ETFs pull in $987 million last week as institutional demand recovers
Silver Price Forecast: XAG/USD dips below $66.00 and hints at a bearish “H&S”
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well
Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.
